1849-S - Enzymes for Scale Up Activities for Vaccines Project
key details
| Value | £379,440 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East |
| Deadline | 30 Jul 2020 |
| Contract start | 31 Jul 2020 |
| Contract end | 28 Feb 2021 |
| Procedure | limited |
| SME suitable | No |
| OCID | ocds-b5fd17-135ff539-8548-46ed-80da-ab486cebf168 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| NEW ENGLAND BIOLABS (U.K.) LIMITED | £379,440 | 29 Jul 2020 | active |
description
CPI require a number of enzymes to use as part of its response to COVID-19 vaccine project.
The Public Contract Regulations 2015 state in regulation 32.2) The negotiated procedure without prior publication may be used for public works contracts, public supply contracts and public service contracts in any of the following cases:- (b)where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons:-
(ii)competition is absent for technical reasons.
The technical transfer of the current manufacturing process CPI are receiving is based upon use of prespecified enzymes. Due to operating under GMP conditions, we are therefore restricted to the same supplier to ensure that we do not deviate from their existing process.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 17 Aug 2020 | Award (award) | · | 7dbe5fe1-fa86-46e1-a869-0df5225e99dc-376188 |
more from CENTRE FOR PROCESS INNOVATION LIMITED
- Grant Audits · 6 Feb 2026
- AWS support to develop data flows · £52,463 · 3 Feb 2026
- Service contract renewal for EMS · £51,785 · 3 Feb 2026
- Cycle to Work Scheme · 3 Feb 2026
- Framework for the Provision of Siemens Equipment, Software and Other Services · £20,000,000 · 2 Feb 2026
- IT Research and Advisory services · £76,500 · 19 Dec 2025
- BSOL Subscriptions · £45,064 · 19 Dec 2025
- Utilities - Gas · £1,000,000 · 4 Nov 2025
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.